Physician profile
Gerald D Chitters
NPI 1366452310
$2,600.49
in general payments reported to CMS, 2019-2025
18 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $299 · 2020: $231 · 2021: $456 · 2022: $615 · 2023: $310 · 2024: $216 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $714.72 | 2022-2025 | Lybalvi, Aristada |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $472.52 | 2021-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $263.21 | 2019-2025 | Fanapt |
| Allergan, INC. | $240.33 | 2019-2020 | |
| Lundbeck LLC | $219.26 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $171.91 | 2022-2024 | Ingrezza |
| Ironshore Pharmaceuticals INC. | $99.05 | 2019 | |
| Abbvie INC. | $73.07 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $72.45 | 2024-2025 | Cobenfy |
| Corium, LLC | $56.99 | 2022-2023 | Azstarys |
| Eisai INC. | $53.39 | 2021 | |
| Supernus Pharmaceuticals, INC. | $38.69 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $34.94 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $22.51 | 2024 | Uzedy |
| Bausch Health US, LLC | $19.57 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $17.50 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.94 | 2021 | |
| Tris Pharma INC | $14.44 | 2023 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Chitters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.